Resverlogix Corporation

Resverlogix Corporation Resverlogix Corporation is a publicly traded biotechnology company (RVX: TSX) focused on groundbreaking research in the areas of cardiovascular disease, cancer, and fibrotic diseases.

Contact Details: 202, 279 Midpark Way SE Calgary Alberta T2X 1M2 Canada Tel: 403.254.9252 Fax: 403.256.8495 Email: info@resverlogix.com WWW: www.resverlogix.com/

Loading...

BioNews Results for Resverlogix Corporation:
Emerging Drug Developer: Resverlogix	FierceBiotech:  Nov 9 2009 4:34PM Matching: resverlogix
Resverlogix Commends Dr. William Cochrane's Induction into the Canadian Medical Hall of Fame	Individual.com:  Oct 27 2009 10:23PM Matching: resverlogix
Resverlogix Commends Dr. William Cochrane's Induction into the Canadian Medical Hall of Fame	CNW Telbec:  Oct 26 2009 1:48PM Matching: resverlogix
Resverlogix Commends Dr. William Cochrane's Induction into the Canadian Medical Hall of Fame	Therapeutics Daily:  Oct 26 2009 2:19PM Matching: resverlogix
Resverlogix Commends Dr. William Cochrane's Induction into the Canadian Medical Hall of Fame	Yahoo! Canada:  Oct 26 2009 2:14PM Matching: resverlogix
Promote your company here: BioNewsCast - Press Release Distribution	→View more Resverlogix Corporation news.

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 336 times since April 2007, the link to the organisation's website has been followed 54 times

Recent Search Terms used to find this page: resverlogix 2009 | resverlogix | .

Search for more companies in Calgary

Search for more companies in Alberta

This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for Resverlogix Corporation